2017 National Fall Meeting – Key Speaker – Jeff Curtis, MD, University of Alabama at Birmingham

Final speakers and details are getting locked into place for the upcoming United Rheumatology Fall Meeting at the Hyatt Regency Orlando in Orlando, Florida (Oct. 20-21).
A key theme of the meeting will be the role of clinical data in assuring a sustainable independent rheumatology practice. Increasingly, new payment arrangements focus on meeting measurable cost and quality objectives. United Rheumatology will be sharing with attendees how we plan to help you negotiate with payers from a position of strength, powered by our ability to measure quality and cost. Among other partners and speakers, United Rheumatology has teamed up with Jeff Curtis, MD, University of Alabama at Birmingham, to share insights into the demand for real-world evidence from payers and PBMs, and how your practice’s EMR data can provide a strategic advantage in these negotiations and conversations.
Jeff Curtis, MD
University of Alabama at Birmingham
“Real World Data and the Community Rheumatologist”
Dr. Curtis is a Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB). He currently holds the William J. Koopman Endowed Professorship in Rheumatology and Immunology at UAB. He is the Co-Director of the UAB Center for Education and Research on Therapeutics (CERTs) of Musculoskeletal Disorders, which has a major emphasis on evaluating the safety and comparative effectiveness of medications for rheumatic diseases. Additionally, as the Director of the UAB Arthritis Clinical Intervention Program, he leads the clinical trials unit for the rheumatology division at UAB, with a particular focus on rheumatoid arthritis (RA) and psoriatic arthritis (PsA). He is the Co-Director of the UAB Pharmacoepidemiology and Pharmacoeconomics Research (PEER) Unit. PEER uses multiple large data sources to study comparative effectiveness questions across multiple chronic diseases. These data sources include national administrative data from Medicare and commercial health plans, electronic health record data, and large registries.
The evaluation of the efficacy, comparative effectiveness, and safety of the medications used to treat rheumatoid arthritis and spondyloarthritis are among Dr. Curtis’s research interests. He served on the Core Expert Panel for the ACR’s 2008, 2012, and 2015 Recommendations for the Use of Nonbiologic and Biologic Disease Modifying Antirheumatic Drugs in RA. He was the Deputy Director for a collaborative project between the FDA, the Agency for Healthcare Research and Quality (AHRQ), and a number of academic centers studying the safety of biologic agents using multiple, pooled national data sources.
Register now for United Rheumatology’s National Meeting – October 20-21, 2017, Hyatt Regency Orlando, Orlando, FL.
*UR will reimburse you for your airfare (coach round trip) as well as your hotel room on Friday night. (Attendees only)
Please click here for more information and to register.

Become a Member

Whether you have an established practice, you’re fresh out of your fellowship, or you’re a hospital-based rheumatologist considering private practice, United Rheumatology offers the resources and services you need to advance your career and your clinic.


Find a UR Rheumatologist Near Me

© 2023 United Rheumatology